ClinicalTrials.Veeva

Menu

Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom (ESDUK)

P

Portsmouth Hospitals NHS Trust

Status

Enrolling

Conditions

Endoscopic Submucosal Dissection

Treatments

Procedure: Endoscopic Submucosal Dissection

Study type

Observational

Funder types

Other

Identifiers

NCT03039309
PHT/2016/45

Details and patient eligibility

About

Multicentre cohort study on the use of endoscopic submucosal dissection for the treatment of early gastrointestinal neoplasia.

Full description

Data will be collected from participating centres on en bloc resection, curative resection, R0 resection and complications/adverse events over a 2 year follow up period.

Demographic details on the patients included in the study will be captured alongside details on the size and location of their early gastrointestinal dysplastic/neoplastic lesions.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or Female, aged 18 years or above undergoing endoscopic submucosal dissection
  • Participant is able to give informed consent for participation in the study

Exclusion criteria

  • Patients under the age of 18
  • Patients unable to give informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Sharmila Subramaniam, MBBS; Prof Pradeep Bhandari, MBBS, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems